Expand SDGR Menu
SDGR MENU

SDGR Latest Press Releases

-- December 9, 2025 --

Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions PRNewswire 11:58 AM

-- November 6, 2025 --

Schrdinger to Present at Jefferies London Healthcare Conference Business Wire 8:30 AM

-- November 5, 2025 --

Schrdinger Reports Third Quarter 2025 Financial Results Business Wire 4:05 PM

-- October 30, 2025 --

Copernic Catalysts Announces Achievement of Ammonia Catalyst Milestone in Research Collaboration with Schrdinger Business Wire 7:30 AM

-- October 22, 2025 --

Schrdinger to Announce Third Quarter 2025 Financial Results on November 5 Business Wire 8:30 AM

-- October 15, 2025 --

Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Business Wire 8:30 AM

-- September 18, 2025 --

Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Business Wire 8:30 AM

-- August 27, 2025 --

Schrdinger to Present at Morgan Stanley Global Healthcare Conference Business Wire 8:30 AM

-- August 15, 2025 --

Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:30 PM

-- August 14, 2025 --

Schrdinger Announces Discontinuation of SGR-2921 Program Business Wire 7:00 AM

-- August 6, 2025 --

Schrdinger Reports Second Quarter 2025 Financial Results Business Wire 4:05 PM

-- July 25, 2025 --

Schrdinger to Announce Second Quarter 2025 Financial Results on August 6 Business Wire 8:30 AM

-- July 18, 2025 --

Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Business Wire 8:00 AM

-- July 17, 2025 --

Ajax Therapeutics and Schrdinger Expand Research Collaboration to Include Additional JAK Target Business Wire 8:00 AM
Market Data Delayed 15 Minutes